For Pharma & Clinical Research

The functional vision data your trial is missing between visits.

Capture continuous patient-generated functional vision data between site visits for stronger endpoints, earlier signal detection, and real-world evidence beyond the clinic.

Regulatory-ready infrastructureMulti-site operational supportBYOD patient workflows
Researcher reviewing clinical trial data on a monitor in a pharmaceutical laboratory

The Challenge

Site visits capture moments.Trials need trajectories.

EyeCTester extends your visibility window from quarterly snapshots into a continuous functional record without adding site visits or patient travel.

Outcomes For Trials

What continuous endpoints enable

01

Continuous Real-World Evidence

Longitudinal functional data supports regulatory submissions, post-market evidence requirements, and commercial differentiation.

02

Earlier Signal Detection

See the shape of response curves rather than only scheduled snapshots.

03

Reduced Site Burden

Remote daily testing lowers coordinator burden and can improve enrollment and retention.

04

Regulatory-Ready Data Output

Structured, audit-trailed exports accelerate submission preparation.

Trial Infrastructure

Trial-ready infrastructure

FDA 510(k) Cleared SaMD

Validated under the FDA regulatory framework for visual function assessment.

Standardized 4-test battery

Visual Acuity, Contrast Sensitivity, Color, and Amsler & Central Visual Field in a protocol-ready workflow.

HIPAA-compliant infrastructure

AWS-hosted, role-based access controls, and breach procedures support clinical operations.

Protocol-aligned configuration

Visit schedule, test frequency, alert thresholds, and assessment windows can be configured per protocol.

Multi-site ready

Centralized sponsor dashboard with site-level visibility and multilingual patient support.

Therapeutic Areas

Validated across therapeutic areas

ConditionEyeCTester Application
AMD (Dry & Wet)
Visual acuity, Amsler, and contrast sensitivity longitudinal tracking between injections and follow-up visits.
Diabetic Retinopathy / DME
Inter-visit functional monitoring that helps identify response variability and change between anti-VEGF treatments.
Glaucoma
Functional trend monitoring between site visits to complement annual perimetry.
Geographic Atrophy
Trajectory assessment and conversion surveillance via longitudinal metamorphopsia tracking.
Optic Neuritis
Visual acuity and color vision recovery tracking between site assessments.
Neuro-ophthalmic Conditions
Bilateral monitoring and asymmetric fellow-eye change detection.

Explore EyeCTester for your clinical program.

Partnering with pharma and research teams in retina, glaucoma, and neuro-ophthalmology.